Objective-We investigated the hypothesis that HDL (high-density lipoprotein) dysfunction in Scarb1 −/− mice negatively affects cardiac function both in the absence and in the presence of pressure overload. Second, we evaluated whether normalization of HDL metabolism in Scarb1 −/− mice by hepatocyte-specific SR-BI (scavenger receptor class B, type I) expression after E1E3E4-deleted adenoviral AdSR-BI (E1E3E4-deleted adenoviral vector expressing SR-BI protein in hepatocytes) transfer abrogates the effects of total body SR-BI deficiency on cardiac structure and function. Approach and Results-Transverse aortic constriction (TAC) or sham operation was performed at the age of 14 weeks, 2 weeks after saline injection or after gene transfer with AdSR-BI or with the control vector Adnull. Mortality rate in Scarb1 −/− TAC mice was significantly increased compared with wild-type TAC mice during 8 weeks of follow-up (hazard ratio, 2.02; 95% CI, 1.14-3.61). Hepatocyte-specific SR-BI gene transfer performed 2 weeks before induction of pressure overload by TAC potently reduced mortality in Scarb1 −/− mice (hazard ratio, 0.329; 95% CI, 0.180-0.600). Hepatocyte-specific SR-BI expression abrogated increased cardiac hypertrophy and lung congestion and counteracted increased myocardial apoptosis and interstitial and perivascular fibrosis in Scarb1 −/− TAC mice. Scarb1 −/− sham mice were, notwithstanding the absence of detectable structural heart disease, characterized by systolic and diastolic dysfunction and hypotension, which were completely counteracted by AdSR-BI transfer. Furthermore, AdSR-BI transfer abrogated increased end-diastolic pressure and diastolic dysfunction in Scarb1 −/− TAC mice. Increased oxidative stress and reduced antioxidant defense systems in Scarb1 −/− mice were rescued by AdSR-BI transfer. Conclusions-The detrimental effects of SR-BI deficiency on cardiac structure and function are nullified by hepatocytespecific SR-BI transfer, which restores HDL metabolism. Visual Overview-An online visual overview is available for this article.
T he HDL (high-density lipoprotein) receptor SR-BI (scavenger receptor class B, type I) is a key regulator of lipoprotein metabolism and cholesterol homeostasis.
1 SR-BI binds HDL with high affinity and is expressed primarily in the liver and nonplacental steroidogenic tissues. 2 Selective uptake of cholesterol by hepatic SR-BI and subsequent routing into bile is a major route of delivery of peripheral cholesterol to the liver for excretion in both mice and humans. 1 Hepatic SR-BI also brings about the selective uptake of HDL lipid hydroperoxides. 3, 4 By mediating the selective uptake of HDL lipids, hepatic SR-BI activity modulates the composition of HDL and maintains HDL function. 4 Scarb1-deficient mice, lacking SR-BI protein expression, are characterized by increased plasma cholesterol comprising predominantly enlarged HDL enriched in free cholesterol and apo (apolipoprotein) E. 5 The increase of free cholesterol/total cholesterol ratio in Scarb1-deficient mice is because of the decreased efficiency of large HDL particles enriched in sphingomyelin to activate LCAT (lecithin:cholesterol acyltransferase). [6] [7] [8] SR-BI also mediates the bidirectional flux of free cholesterol between peripheral cells and HDL. 9 Epidemiological and experimental studies provide converging lines of evidence that HDL may exert direct effects on the myocardium and that HDL may protect against the development of heart failure. 10, 11 In Framingham Heart Study participants free of coronary heart disease at baseline, low HDL cholesterol levels were independently associated with heart failure incidence after adjustment for interim myocardial infarction and clinical covariates. 12 Increased HDL after human apo A-I gene transfer inhibits the development of diabetic cardiomyopathy in rats, 13 increases myocardial capillary density and diastolic function in hypercholesterolemic mice, and reduces infarct expansion, attenuates left ventricular dilatation, and improves systolic and diastolic cardiac function postmyocardial infarction in mice. 15 Moreover, reconstituted HDL shortens repolarization of isolated rabbit cardiomyocytes, 16 and infusion of reconstituted HDL shortens the heart rate-corrected QT interval on surface electrocardiograms in humans. 16 Recently, it has been demonstrated that HDL inhibits mechanical stress-induced hypertrophic responses in cultured cardiomyocytes and counteracts cardiac hypertrophy in vivo 4 weeks after transverse aortic constriction (TAC). 17, 18 Lack of hepatic SR-BI activity results in the accumulation of enlarged, dysfunctional HDL and induces HDL dysfunction, characterized by a reduced capacity to promote cholesterol efflux, a decreased antioxidative potential resulting in increased oxidative stress, and impaired anti-inflammatory and prosurvival signaling. 1, 4 In the current study, we investigated the hypothesis that dysfunctional HDL in Scarb1 −/− mice induces cardiac dysfunction and that normalization of HDL metabolism in Scarb1 −/− mice by hepatocyte-specific E1E3E4-deleted adenoviral SR-BI gene transfer restores cardiac function in these mice. Second, we evaluated whether dysfunctional HDL in Scarb1 −/− mice potentiates cardiac hypertrophy induced by TAC and whether dysfunctional HDL aggravates pressure overload-induced cardiomyopathy. Furthermore, we hypothesized that restoration of HDL metabolism via hepatocyte-specific E1E3E4-deleted adenoviral SR-BI gene transfer abrogates these effects in mice with pressure overload.
Materials and Methods
The data that support the findings of this study are available from the corresponding author upon reasonable request. Details of the major resources and detailed methodology can be found in the online-only Data Supplement.
Production of the Murine SR-BI Expressing Vector AdSR-BI
The recombinant E1E3E4-deleted adenoviral vector AdSR-BI (E1E3E4-deleted adenoviral vector expressing SR-BI protein in hepatocytes) contains the 1.2 kb DC172 promotor, 19 consisting of an 890 bp human α1-antitrypsin promoter and 2 copies of the 160 bp α 1 -microglobulin enhancer, upstream of the 5′ untranslated region of the human apo A-I gene that contains the first intron, the 2.5 kb murine Scarb1 sequence, 2 2 copies of the 774 bp hepatic control region-1, and the SV40 polyadenylation signal. The E1E3E4-deleted control vector Adnull does not contain an expression cassette. 20 Construction of infectious plasmids and large-scale production of recombinant E1E3E4-deleted adenoviral vectors was performed as described previously.
20
Production of the Human Apo A-I Expressing Vector AAV8-A-I HDL-raising gene transfer was performed using an adeno-associated viral serotype 8 (AAV8) vector containing a hepatocytespecific expression cassette to induce expression of human apo A-I (AAV8-A-I). 21 The expression cassette of this vector consists of the 1.2 kb DC172 promoter, comprising an 890 bp α1-antitrypsin promoter fused together with 2 copies of the 160 bp α1-microglobulin enhancer, upstream of the 2 kb genomic human apo A-I sequence, 1 copy of the 774 bp hepatic control region-1, and the rabbit β-globin polyadenylation signal (127 bp). The control vector AAV8 null contains the transcriptional regulatory sequences but no genomic human apo A-I insert. AAV vector production was performed as described.
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In Vivo Experiments
All experimental procedures in animals were performed in accordance with protocols approved by the Institutional Animal Care and Research Advisory Committee of the Catholic University of Leuven (Approval number: P154/2013). Female Scarb1-null mice 5 lacking protein expression of scavenger receptor class B, type I (SR-BI), and female wild-type mice were fed standard chow diet (Sniff Spezialdiäten GMBH, Soest, Germany) for the entire duration of the experiment. Scarb1-null mice were originally generated by Rigotti et al. 5 All Scarb1-null mice and wild-type mice were obtained from heterozygous Scarb1 +/− breeding couples with 75% C57BL/6 and 25% 129 genetic background. At the age of 12 weeks, female Scarb1-null mice were injected with saline buffer or with 5×10 10 viral particles of Adnull or with the same dose of AdSR-BI. Half of control Scarb1-null mice were injected with saline buffer and the other half with Adnull. The equivalency of Adnull and saline injection with regard to different outcome measures has been demonstrated in several studies. 14, [23] [24] [25] [26] In an independent experiment, female Scarb1 −/− mice were injected with 5×10 10 viral particles of AdSR-BI in combination with 5×10 10 genome copies of AAV8-A-I or in combination with 5×10 10 genome copies of AAV8 null. To induce pressure overload, TAC was performed at the age of 14 weeks as described. 26 In brief, anesthesia was performed with a single intraperitoneal injection of sodium pentobarbital (Nembutal; Ceva Sante Animale, Brussels, Belgium) at a dose of 40 to 70 mg/kg. Mice were put in supine position, and temperature was maintained at 37°C with a heating pad. A horizontal skin incision of 0.5 to 1 cm in length was made at the level of the suprasternal notch. A 2 to 3 mm longitudinal cut was performed in the proximal portion of the sternum, and the thymus gland was retracted. This allowed visualization of the aortic arch under low-power magnification. A wire with a snare at the end was passed under the aorta between the origin of the right innominate artery and the left common carotid artery. A 7-0 silk suture (Cat No. W817; Ethicon; Johnson & Johnson, Livingston, Scotland) was snared with the wire and pulled back around the aorta. Subsequently, a bent 27-gauge needle (BD Microlance; BD, Franklin Lakes, New Jersey) was placed next to the aortic arch, and the suture was snugly tied around the needle and the aorta. Afterward, the needle was quickly removed. The skin was closed, and mice were allowed to recover on a warming pad until they were fully awake. The sham procedure was identical except that no constriction on the aorta was applied. Samples were subjected to electrophoresis for 60 minutes at 3 mA per gel tube set at maximum delivery of 500 V. Bands were identified based on migration distance according to the instructions of the manufacturer.
Plasma Lipoprotein Analysis
HDL Isolation by Density Gradient Ultracentrifugation
Plasma HDL (1.063 g/mL<d<1.21 g/mL) was isolated from murine plasma by density gradient ultracentrifugation in a swing-out rotor as described. 28 HDL was subsequently dialyzed against PBS and concentrated. Protein concentration of HDL was determined using a bicinchoninic protein assay kit.
Isolation of Adult Murine Cardiomyocytes
Adult murine cardiomyocytes were isolated for cell culture based on a simplified, Langendorff-free method as described in detail by Ackers-Johnson et al 29 and in the online-only Supplement.
Quantification of Global Cholesterol Efflux Capacity
Cholesterol efflux capacity was quantified at Vascular Strategies LLC (Plymouth Meeting, PA). Serum HDL (apoB-depleted serum) was prepared from individual serum samples by precipitation of apoBcontaining lipoproteins using polyethylene glycol (Cat No. P2139; Sigma-Aldrich, St. Louis, MO). In brief, for each serum sample, 100 parts serum was mixed with 40 parts polyethylene glycol (20%, v/v, in glycine buffer, pH 7.4). The mixture was incubated at room temperature for 20 minutes and then centrifuged at 10 000 rpm for 30 minutes at 4°C. The supernatant containing serum HDL was collected and used for analysis of cholesterol efflux capacity. Subsequently, global cholesterol efflux capacity of serum HDL samples was determined as described in detail elsewhere. 30, 31 In brief, global cholesterol efflux was measured using J774 mouse macrophage cells (kindly provided by George Rothblat, The Children's Hospital of Philadelphia, University of Pennsylvania). J774 cells were preincubated with 2 µCi/mL 30 The intra-assay coefficient of variation for global cholesterol efflux is 6%.
Statistical Analysis
All data are expressed as means±SEM. Parameters between 3 groups were compared by 1-way ANOVA followed by Bonferroni multiple comparisons post test for comparing sham groups, TAC groups, and sham versus respective TAC groups using GraphPad Instat (GraphPad Software, San Diego). When the assumption of sampling from populations with identical SDs was not met, a logarithmic transformation was performed. When the assumption of sampling from populations with Gaussian distributions was not met, a Kruskal-Wallis test was performed followed by Dunn multiple comparisons post test. Parameters between 2 groups were compared using Student t test. When indicated, a logarithmic transformation or a nonparametric Mann-Whitney test was performed. The assumption of Gaussian distribution was tested using the method Kolmogorov and Smirnov. Kaplan-Meier survival curves were analyzed by log-rank test using Prism4 (GraphPad Software). A 2-sided P value of <0.05 was considered statistically significant.
Results
SR-BI Expression After AdSR-BI Gene Transfer Is Stable and Restricted to Parenchymal Liver Cells
Murine SR-BI protein expression was evaluated in wild-type mice, Scarb1 −/− mice, and Scarb1 −/− treated with 5×10 10 viral particles of AdSR-BI. AdSR-BI is an E1E3E4-deleted adenoviral vector containing a hepatocyte-specific expression cassette, which is illustrated in Figure IA To demonstrate that murine SR-BI expression in AdSR-BI Scarb1 −/− mice is restricted to parenchymal liver cells, immunofluorescence microscopy was applied to visualize SR-BI expression and the hepatocyte-specific antigen-4α ( Figure II in the online-only Data Supplement). Merged images show that SR-BI expression and hepatocyte-specific antigen-4α antigen colocalize in AdSR-BI Scarb1 −/− mice, indicating that in these mice SR-BI expression is restricted to parenchymal liver cells (hepatocytes).
AdSR-BI Gene Transfer Restores Lipoprotein Profile in Scarb1-Null Mice
The study design of the main experiments of the current investigation is illustrated in Figure IB in the online-only Data Supplement. At the age of 12 weeks, female Scarb1 −/− mice were injected with saline buffer or with 5×10 10 viral particles of Adnull or with the same dose of AdSR-BI. TAC was performed at the age of 14 weeks to induce pressure overload or alternatively, sham operation was performed. Total cholesterol, HDL cholesterol, and non-HDL cholesterol levels are shown in Figure 1G , 1H, and 1I, respectively. Total cholesterol and HDL cholesterol levels were 2.70-fold (P<0.001) and 2.74-fold (P<0.001) higher, respectively, in Scarb1 −/− sham mice than in wild-type sham mice. Lipoprotein cholesterol levels were very similar in AdSR-BI-treated Scarb1 −/− sham mice compared with wild-type sham mice. The free cholesterol/total cholesterol ratio was 1.41-fold (P<0.001) higher in Scarb1 −/− sham mice than in wild-type sham mice ( Figure 1J ). Lipoprotein cholesterol levels and the free cholesterol/total cholesterol ratio were very similar in TAC groups compared with respective sham groups (Figure 1 ). 
Global Cholesterol Efflux Is Not
Hepatocyte-Specific SR-BI Expression After AdSR-BI Gene Transfer in Scarb1-Null Mice Abrogates Increased Mortality After TAC
Comparison of Kaplan-Meier survival curves after TAC showed a significantly (P<0.05) increased mortality rate in Scarb1 −/− mice compared with wild-type mice during a follow-up period of 8 weeks (hazard ratio for mortality, 2.02; 95% CI, 1.14-3.61; Figure IIID caspase-3-positive cells and Sirius red-stained interstitial collagen in sham mice and TAC mice are shown in Figure 3D , respectively.
Hepatocyte-Specific SR-BI Expression After AdSR-BI Gene Transfer Corrects Cardiac Dysfunction in Scarb1 −/− Sham Mice and Abrogates Increased End-Diastolic Pressure and Diastolic Dysfunction in Scarb1 −/− TAC Mice
Because hemodynamic parameters should not be compared in mice with a huge difference in afterload, data in sham mice (Table 1 ) and in TAC mice ( Figure 5A ). These elevations were abrogated by hepatocyte-specific SR-BI gene transfer. An entirely similar pattern was observed for the 3-nitrotyrosine-positive area in the myocardium ( Figure 5B ). Xanthine oxidase activity was significantly (P<0.0001) increased in the 3 TAC groups compared with respective sham groups ( Figure 5C ). Xanthine oxidase activity was 3.94-fold (P<0.001) and 1.94-fold (P<0.001) higher in Scarb1 −/− sham mice and Scarb1 −/− TAC mice, respectively, compared with respective wild-type groups. These elevations were abrogated by hepatocyte-specific SR-BI gene transfer ( Figure 5C Figure 5E ). AdSR-BI gene transfer restored antioxidant defense systems ( Figure 5D and 5E). Representative myocardial sections immunostained for 3-nitrotyrosine are shown in Figure 5F .
Interleukin-6 levels were 2.98-fold (P<0.05) higher in AAV8-A-I gene transfer in TAC mice resulted in an enhanced systolic cardiac function as evidenced by a 1.26-fold (P<0.05) increase of dP/dt max and a strengthened diastolic cardiac function as evidenced by a lower end-diastolic pressure (P<0.05), a 21.6% (P<0.01) increase of dP/dt min , and an 11.9% (P<0.05) decrease of the time constant of isovolumetric relaxation (Table 3) . Taken together, HDL-targeted AAV8-A-I gene transfer results in a further improvement of cardiac function and in a further attenuation of left ventricular hypertrophy in AdSR-BI Scarb1 −/− TAC mice.
Discussion
The main findings of the current study are that (1) hepatocyte-specific SR-BI gene transfer in Scarb1 −/− sham mice normalizes lipoprotein profile and corrects cardiac dysfunction, which is characterized by systolic and diastolic dysfunction and by hypotension; (2) increased mortality after TAC in Scarb1 −/− mice compared with wild-type mice is completely antagonized by hepatocyte-restricted SR-BI expression after AdSR-BI gene transfer; (3) AdSR-BI gene transfer abrogates −/− TAC mice as evidenced by increased wet lung weight is prevented by hepatocyte-specific SR-BI expression after AdSR-BI gene transfer, which lowers end-diastolic pressure and improves diastolic function; and (5) increased oxidative stress and reduced antioxidant defense systems in Scarb1 −/− mice are rescued by hepatocyte-restricted SR-BI expression after AdSR-BI gene transfer.
The current study evaluated the effects of Scarb1 deficiency and of hepatocyte-specific SR-BI expression after AdSR-BI gene transfer both in the absence and in the presence of pressure overload. The study was restricted to female mice because significant sex differences in the degree of left ventricular hypertrophy after TAC exist. 32, 33 This sex difference will decrease the statistical power of a study in which mice of both sexes are compared. It is reasonable to assume that the observed effects are reproducible in male mice. The E1E3E4-deleted vector that was used in the current study induces persistent and stable transgene expression. 19, 20 Whereas significant structural differences were observed between the 3 TAC groups, no detectable structural differences were observed between the 3 sham groups. Nevertheless, cardiac dysfunction was evident in Scarb1-deficient sham mice as evidenced by hypotension and impaired systolic and diastolic function and was completely abrogated by hepatocyte-specific SR-BI expression after AdSR-BI gene transfer. Lack of hepatic SR-BI activity results in the accumulation of enlarged and dysfunctional HDL, which fails to enhance myocardial function. In contrast, properly functioning HDL may exert direct effects on cardiomyocytes as they shorten the ventricular action potential. 16, 34 HDL has previously been demonstrated to induce the phosphorylation of connexin 43 35 and the phosphorylation of PI3K (phosphoinositide 3-kinase)/Akt, ERK1/2, p38 MAPK, and the transcription factor STAT3. 36 Activation of these proteins may play a role in the cardioprotective effects of HDL. 35, 36 Here, we show that HDL isolated from Scarb1 −/− mice fails to activate Akt, ERK1/2, p38 MAPK, and STAT3. The dysfunction of HDL with regard to the activation of these proteins may play an important role in the impaired cardiac function in Scarb1 −/− mice. In addition, the effect of HDL in vivo may be mediated via endothelial cells. Endothelial cells in the heart have been proposed to play an essential role in regulating and maintaining cardiac function, in particular, at the endocardium and in the myocardial capillaries where endothelial cells directly interact with adjacent cardiomyocytes. 37 Therefore, the effect of HDL in vivo on cardiomyocyte function might also be indirect via paracrine effects between endothelial cells and cardiomyocytes. After all, endothelial cells constitute the predominant cell type in the mammalian heart. Cardiomyocytes constitute ≈30% of the cells in the mammalian heart, whereas nonmyocyte cells comprise 70% of cardiac cells. 38, 39 Pinto et al 40 have recently demonstrated using several independent methodological approaches in mice that endothelial cells constitute 64%, hematopoietic-derived cells 9%, fibroblast 15%, and nonfibroblast resident mesenchymal cells 12% of nonmyocyte cells in mice. Our results with E1E3E4-deleted AdSR-BI gene transfer indicate that SR-BI expression in the myocardium is not required for the effects of HDL because the expression cassette of the vector restricts transgene expression to parenchymal liver cells. 19 Normalization of HDL metabolism after AdSR-BI gene transfer may enhance apo A-I-induced cell signaling either directly via ABCA1 or indirectly via β-ATPase and P2Y 12/13 ADP receptor. 41 In addition, normalization of HDL metabolism after AdSR-BI gene transfer may enhance cholesterol efflux in vivo mediated via ABCA1 or via ABCG1. Enhanced cholesterol efflux may regulate cholesterol distribution between the raft and nonraft membrane fractions and may indirectly affect signal transduction induced by other ligands. 41 Furthermore, microdomain-specific localization of ion channels may affect their function. 42 Increased mortality after TAC in Scarb1 −/− mice compared with wild-type mice is completely antagonized by hepatocyterestricted SR-BI expression after AdSR-BI gene transfer. The increased mortality in Scarb1 −/− TAC mice compared with the other 2 TAC groups may reflect the proarrhythmic effect of dysfunctional HDL or may be because of a reduced potential of Scarb1 −/− TAC mice for acute adaptation to hemodynamic overload. In contrast to sham data, survival bias should be taken into account in the comparison of Scarb1 −/− TAC mice and the other 2 TAC groups for different end points at 8 weeks after the induction of pressure overload. Scarb1 −/− TAC mice were characterized by more pronounced left ventricular hypertrophy, interstitial and perivascular fibrosis, and myocardial apoptosis. Pathological hypertrophy is characterized by fibrotic remodeling, by capillary rarefaction, and by cardiomyocyte death, which promote cardiac dysfunction and development of heart failure. 43 Whereas the data in sham mice indicate that cardiac TAC mice as evidenced by the significantly increased lung weight compared with the other 2 TAC groups. These data suggest that functional HDL may beneficially affect the myocardium both by electrophysiological effects and by modulating cardiac remodeling.
Whereas pressure overload is obviously the primary trigger for cardiac remodeling after TAC, increased oxidative stress may underlie the more prominent pathological remodeling in Scarb1 −/− TAC mice. Reactive oxygen species and oxidative stress are important contributors to the pathophysiology of heart failure influencing many key aspects of the failing heart phenotype such as hypertrophy, matrix remodeling, contractile dysfunction, arrhythmia, and cell viability. 44 The serum paraoxonase and arylesterase activity of the antioxidant enzyme PON1 associated with HDL were reduced in Scarb1 −/− mice. 4 SR-BI also plays an important role in the selective removal of oxidized cholesterol from HDL. 45 Scarb1 −/− mice have been shown to be characterized by oxidative stress. 4 In the current study, we demonstrate increased oxidative stress in the plasma and in the myocardium in both Scarb1 −/− sham mice and Scarb1 −/− TAC mice. In addition, increased pro-oxidant enzyme activities (xanthine oxidase) and reduced antioxidant defense systems (superoxide dismutase and thioredoxin reductase) were observed in Scarb1 −/− mice, which may have a profound impact on the intracellular redox state. In contrast, human apo A-I gene transfer in diabetic rats reduced nicotinamide adenine dinucleotide phosphate NADPH oxidase activity and counteracted endothelial nitric oxidase uncoupling, 46 suggesting opposing effects of functional and dysfunctional HDL on the intracellular redox state.
The antioxidative and cholesterol efflux capacities of HDL have been shown to be reduced in patients with ischemic cardiomyopathy. 47 Whereas it cannot be established whether reduced HDL function in these patients reflects cause or consequence, the data of the current murine study support the view that HDL function may modulate the progression of clinical heart failure. 47 In line with its scavenging function, SR-BI not only binds HDL particles but also contributes to the clearance of native and modified LDL (low-density lipoprotein) particles, IDL (intermediate-density lipoproteins), VLDL (very-lowdensity lipoproteins), and chylomicrons. [48] [49] [50] [51] The absence of a difference in murine apoB levels may be explained by the fact that SR-BI promotes on the one hand the catabolism of apoB-containing lipoproteins and augments on the other hand the VLDL-apoB production rate. 52 Although non-HDL cholesterol levels are increased in Scarb1 Studies on the role of SR-BI in cardiovascular disease have been mainly focused on atherosclerosis.
1, 48 The current study demonstrates for the first time that hepatic SR-BI deficiency and consequent HDL dysfunction may induce cardiac dysfunction and heart failure in the absence of atherosclerosis. Therefore, the role of HDL and of HDL dysfunction in cardiovascular disease may be extended to heart failure, which constitutes the cardiovascular epidemic of this century. 53 In conclusion, dysfunctional HDL in Scarb1 −/− mice induces cardiac dysfunction in the absence and in the presence of pressure overload and aggravates adverse ventricular remodeling in mice with pressure overload. These detrimental effects of SR-BI deficiency are nullified by hepatocyterestricted SR-BI expression after AdSR-BI gene transfer, which restores HDL metabolism.
